A Admin π Coach β 38.23K Points π Biopharmaceutics and Pharmacokinetic Q. Half life of zero-order process is proportional to of drug. (A) initial concentration (B) final concentration (C) both (a) & (b) (D) none of the above ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (A) initial concentration
V Vikash Gupta π Tutor III β 33.56K Points π Biopharmaceutics and Pharmacokinetic Q. The ratio of maximum safe concentration to minimum effective concentration is called as (A) Therapeutic index (B) Therapeutic range (C) Therapeutic outcome (D) Therapeutic ratio ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (A) Therapeutic index
S Shiva Ram π Master β 30.44K Points π Biopharmaceutics and Pharmacokinetic Q. The mathematical relationship between plasma drug concentration and pharmacological response is called as……….. (A) PK modeling (B) PD modeling (C) PK-PD modeling (D) None of the above ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (C) PK-PD modeling
R Ranjeet π Tutor III β 34.60K Points π Biopharmaceutics and Pharmacokinetic Q. In one compartment open model, the term open indicates input and output is: (A) unidirectional (B) bidirectional (C) non-directional (D) none of the above ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (A) unidirectional
R Rakesh Kumar π Hard Worker β 28.44K Points π Biopharmaceutics and Pharmacokinetic Q. Concentration of drug at peak is known as …………drug concentration. (A) maximum (B) minimum (C) lower (D) none of the above ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (A) maximum
V Vinay π Mover β 28.75K Points π Biopharmaceutics and Pharmacokinetic Q. Constant rate infusion is…….. (A) prevents fluctuations (B) useful when drug has narrow TI (C) Both (a) & (b) (D) none of the above ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (C) Both (a) & (b)
R Ram Sharma π Coach β 193.88K Points π Biopharmaceutics and Pharmacokinetic Q. Constant rate infusion prevents………..in blood levels. (A) fluctuations (B) peak maximum (C) valley minimum (D) all of the above ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (D) all of the above
V Vijay Sangwan π Mover β 28.62K Points π Biopharmaceutics and Pharmacokinetic Q. ………..change in drug kinetics is known as chronokinetics. (A) Time-dependent (B) Dose-dependent (C) Both (a) & (b) (D) None of the above ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (A) Time-dependent
G Gopal Sharma π Tutor III β 38.32K Points π Biopharmaceutics and Pharmacokinetic Q. The primary pharmacokinetic parameter clearance can be calculated by (A) Cl = KV (B) Cl = Dose/AUC (C) Cl = (dA/dt)/C (D) all of the above ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (D) all of the above
G Gopal Sharma π Tutor III β 38.32K Points π Biopharmaceutics and Pharmacokinetic Q. Drug having ……..half-lives take a very short time to achieve plateau concentration. (A) shorter (B) longer (C) intermediate (D) none of the above ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (A) shorter